Key Points

• Women who used Depo-Provera, Depo-SubQ Provera 104, or a generic medroxyprogesterone acetate injection for roughly a year or longer and were later diagnosed with a meningioma may qualify to file a lawsuit. 

• The federal Depo-Provera MDL has grown to more than 3,700 cases, with general causation hearings set for June 24 to 26, 2026 and the first jury trial scheduled for December 7, 2026. 

• Hissey Mulderig & Friend is actively reviewing and filing meningioma claims nationwide on a contingency-fee basis, with no upfront cost and no fee unless the firm recovers compensation. 

Why It Matters

The litigation is entering the phase where early rulings and verdicts begin to set the value of every claim, while filing deadlines tied to your diagnosis date can quietly run out. Confirming whether you qualify now helps protect your legal rights and preserve key evidence before trial outcomes shift the landscape. 

Meningioma From the Depo Shot? You May Qualify

In light of recent developments in the Depo-Provera and meningioma brain tumors litigation, many women have questions about whether they may qualify to file a Depo-Provera brain tumor lawsuit. 

The attorneys at Hissey Mulderig & Friend are actively reviewing claims from women who developed meningioma brain tumors after using the Depo shot, and this guide explains who qualifies, what can strengthen or limit a claim, and where the litigation stands right now. 

Find out whether you may be eligible to file a Depo-Provera lawsuit or to start your claim today by contacting the law firm of Hissey Mulderig & Friend. You can reach us by calling toll-free at 1-866-806-8117, or send us a message using the contact form on this page. 

Who Qualifies for a Depo-Provera Lawsuit

You may qualify to file a Depo-Provera brain tumor lawsuit if all three of the following apply to you: 

• You used Depo-Provera, Depo-SubQ Provera 104, or a generic medroxyprogesterone acetate (MPA) injection 

• You received the shot long enough to show meaningful exposure, generally at least one year, which usually means four or more injections 

• You were diagnosed by a doctor with a meningioma, a tumor that forms in the lining of the brain and spinal cord 

If that describes your situation, you may have a claim even if your last shot was many years ago. The sections below explain each factor, along with the newer issues now shaping eligibility in 2026. 

Where the Depo-Provera Litigation Stands in 2026

The Depo-Provera cases are consolidated in a federal multidistrict litigation (MDL) in the Northern District of Florida, overseen by Judge M. Casey Rodgers.  

As of May 2026, more than 3,700 lawsuits were pending in the MDL, a sharp increase from roughly 1,400 at the start of the year. 

Two developments make timing especially important right now: 

• General causation hearings (June 24 to 26, 2026). The court will evaluate whether the scientific evidence linking Depo-Provera to meningioma is strong enough for expert testimony to reach a jury. This is one of the most consequential phases in any drug injury case. 

• The first bellwether trial (December 7, 2026). A small group of test cases will go before juries, starting with a Florida plaintiff. These early verdicts often shape settlement negotiations for the thousands of remaining claims. 

A separate ruling on federal preemption, which is Pfizer’s argument that federal drug law should block some claims, is also expected. The December 2025 FDA decision to add a meningioma warning to the Depo-Provera label weakened that defense, because manufacturers are generally permitted to strengthen safety warnings on their own. 

The Qualifications to File a Depo-Provera Brain Tumor Lawsuit

1. You used Depo-Provera or a generic verson of the birth control shot

Eligibility covers brand-name Depo-Provera, Depo-SubQ Provera 104, and authorized generic versions of MPA injections. The product history matters: women whose use includes the brand-name shot, even if they later switched to a generic, are often in a stronger position. If you used only a generic version, you may still qualify, and an attorney can review the specifics. Learn more about generic MPA eligibility. 

2. You received the Depo shot for at least one year

Most claims involve at least one year of use, typically four or more injections given once every three months. A 2024 study in the British Medical Journal found that prolonged use of medroxyprogesterone acetate was associated with a significantly higher risk of intracranial meningioma, so duration of use is a central factor. You do not need to calculate your exposure yourself; documenting it is part of the legal process. 

3. You were diagnosed with a meningioma brain tumor

A qualifying diagnosis is usually confirmed by MRI or CT imaging, a neurology or neurosurgery evaluation, or a pathology report. Common subtypes, including sphenoid wing and parasagittal meningiomas, are well represented in the litigation. Even tumors described as “benign” can require surgery, radiation, or years of monitoring. 

What Can Affect or Limit Your Claim

Several issues come up regularly when our attorneys review a potential case: 

• A prior brain tumor history. A meningioma diagnosed before you ever started Depo-Provera can complicate a claim, because the lawsuit must connect the tumor to the drug. 

• Missing records. Many women no longer have decades-old pharmacy or clinic records. You do not need complete records to begin. Here is how to prove Depo-Provera use without full records. 

• Filing deadlines. Every state sets its own statute of limitations, and the clock often starts at diagnosis rather than at your last shot. Our state-by-state statute of limitations guide explains the details, and in many states the discovery rule allows women to file years after their last shot. 

How Hissey Mulderig & Friend Is Handling Depo-Provera Meningioma Claims

Hissey Mulderig & Friend represents women nationwide who developed meningioma brain tumors after using the Depo shot.  

Our law firm is actively investigating and filing claims tied to the MDL, and our attorneys track both the medical research behind these cases and the day-to-day developments in the litigation, from the leadership orders entered earlier this year to the upcoming causation hearings and bellwether trials. 

When you work with the firm, we: 

• Review your treatment history and diagnosis at no cost to determine whether you qualify 

• Help gather medical and pharmacy records on your behalf 

• Handle the Plaintiff Proof of Use and Injury documentation required in the MDL 

• Pursue compensation for medical bills, surgery and radiation costs, lost income, and pain and suffering 

We work on a contingency-fee basis, which means there are no upfront costs and no legal fees unless we recover compensation for you. 

Talk With a Depo-Provera Lawyer and Start Your Claim Today

If you used Depo-Provera, Depo-SubQ Provera 104, or a generic MPA injection and were later diagnosed with a meningioma, you may be eligible to file a lawsuit and pursue compensation.  

With key hearings underway and the first trials approaching, acting now can help protect your rights and preserve important evidence before it becomes harder to obtain. 

Contact Hissey Mulderig & Friend toll-free at 1-866-806-8117, or start your claim today using our free case evaluation form, located at the top of this page. 

Frequently Asked Questions

Do I qualify for a Depo-Provera lawsuit if my last shot was 10 or 15 years ago? Often, yes. Because the discovery rule ties many filing deadlines to your diagnosis date, women frequently qualify even when their last injection was a decade or more ago. 

What if I only used the generic version of the shot? You may still qualify. Brand-name use can strengthen a claim, but women with generic MPA use should still have their history reviewed before assuming they are ineligible. 

How many Depo-Provera shots do I need to have a case? Most claims involve at least one year of use, usually four or more injections, though an attorney can assess shorter or mixed treatment histories. 

Is it too late to join the Depo-Provera lawsuit? No. New cases are still being filed and added to the MDL, and the litigation is moving toward its first trials in December 2026. 

How much does it cost to file a claim with Hissey Mulderig & Friend? Nothing upfront. The firm reviews cases for free and is paid only if it recovers compensation for you.